Showing 301-310 of 8693 results for "".
Toxin Time: What’s New and Exciting with Neuromodulators
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/toxin-time-whats-new-and-exciting-with-neuromodulators/19768/Joel Cohen, MD takes a deep dive into the most recent data on neuromodulators including post-hoc analyses on the potential durability of response. Dr. Cohen also shares updates on Revance’s DAXI, Botox Cosmetic and liquid toxins under development by Galderma and Allergan.DermWireTV: Cassiopea NDA; Drew Barrymore and Paula Abdul Make Endorsements
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-cassiopea-nda-drew-barrymore-and-paula-abdul-make-endorsements/19654/BTL’s new Emtone device targets cellulite via simultaneous thermal monopolar radiofrequency and mechanical targeted pressure energy to increase production of collagen and elastin. Drew Barrymore is brand ambassador for Emsculpt. Cassiopea has submitted a New Drug Application to the FDA seeking markeThe New Vbeam Prima: One Laser System with Endless Potential
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/syneron-v-beam-webinar/19600/Join Gilly Munavalli, MD as he presents an overview of Candela’s newly introduced and powerful Vbeam Prima laser platform and shares his personal experience and successes with the system. Dr. Munavalli will discuss the benefits of the Vbeam Prima’s dual wavelengths and dual cooling options to treatGalderma, Allergan Rosacea News, Dupilumab Data
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-allergan-rosacea-news-dupilumab-data/18591/Galderma Laboratories launched a new pump dispenser design for Mirvaso (brimonidine) Topical Gel, 0.33. The FDA has accepted Allergan's New Drug Application (NDA) filing for oxymetazoline cream 1.0%, an investigational topical prescription product for the treatment of persistent facial erythema assoNeotensil®: A Novel, Noninvasive Solution That Reduces the Appearance of Under-Eye Bags
https://practicaldermatology.com/topics/practice-management/neotensil-a-novel-noninvasive-solution-that-reduces-the-appearance-of-under-eye-bags/19058/Neotensil is the only noninvasive solution clinically proven to reduce the appearance of under-eye bags within an hour, with benefits that last up to 16 hours. Doris Day, MD, discusses the benefits of Neotensil, as well as patient selection, staff training and how to incorporate this unique and effeNew Hope for the Hopeless
https://practicaldermatology.com/issues/august-2025/new-hope-jak-inhibitors-alopecia/36693/Dr. Elizabeth (Lisa) Swanson, a dermatologist and associate medical editor of Practical Dermatology, looks at the critical role of case reports in developing new therapeutic options for patients.Nemluvio Gains Two Major Indications in Europe
https://practicaldermatology.com/series/dermwire-tv/nemluvio-gains-two-major-indications-in-europe/32982/In this week's DermwireTV, Nemluvio is approved for two new indications in Europe; new patient-centric guidelines for generalized pustular psoriasis (GPP) management are unveiled; and in our C-Suite Chats feature, we are joined by the Co-Founder and CEO of Veradermics.Neuromodulators and Dermal Fillers: Dr. Gold
https://practicaldermatology.com/programs/practical-dermatology/neuromodulators-and-dermal-fillers-dr-gold/32694/Michael Gold, MD, talks about the new neurotoxins and applications, as well as fillers, that he covered during "Neuromodulators and Dermal Fillers: What's New, What's Coming and What Are We Doing That's New in 2025" at Maui Derm 2025.What's New in Topical Treatment for Plaque Psoriasis?
https://practicaldermatology.com/conferences/maui-derm-2024/whats-new-in-topical-treatment-for-plaque-psoriasis/20235/Linda Stein Gold, MD, director of dermatology clinical research at Henry Ford Health, discusses what’s new in topical treatment of plaque psoriasis and the importance of an “elegant vehicle” for patients to use in their care regimens.New Toxin Textbook Hits Shelves
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-toxin-textbook-hits-shelves/18321/Available at Wiley-Blackwell and on Amazon.com, “Botulinum Toxins: Cosmetic and Clinical Applications” offers up-to-date info on neuromodulators in the US and abroad, along with tips on how to use them on the face and body. Joel Cohen, MD shares details about his new textbook.